CompanyDrug

Lee’s Pharmaceutical’s Socazolimab Becomes China’s First PD-L1 mAb for Cervical Cancer

CompanyDeals

Zhiyi Biotechnology and Henlius Biotech Partner to Develop Novel Drug Products and Platforms

CompanyDrug

FDA Rejects MSD’s Gefapixant for Chronic Cough Treatment Over Efficacy Concerns

CompanyDeals

Shanghai Novopathway and PONY Biomedicine Join Forces for Pre-Clinical Drug Development Platform

CompanyDeals

GSK Secures Exclusive Rights to Hansoh’s ADC Candidate HS-20093 in New Licensing Deal

CompanyDeals

3SBio Partners with HQ Pharma to Develop and Commercialize Eltrombopag Olamine Dry Suspension

CompanyMedical Device

Zylox-Tonbridge Completes Patient Enrollment for ZENFLEX Study in Germany

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Wins NMPA Approvals for SLE and Lymphoma Drug Candidates

CompanyDrug

RemeGen’s Telitacicept Secures FDA Approval for Global Phase III Study in Primary Sjogren’s Syndrome

Company

Novo Nordisk Foundation Launches $260 Million Initiative to Develop Respiratory Disease Vaccines

CompanyDeals

LianBio Board Turns Down Concentra Biosciences Buyout Offer

CompanyDeals

Gilead Acquires Pre-Clinical IL-18BP Targeting Antibody Candidate from Compugen in $848 Million Deal